Data as of Mar 07
| +0.07 / +1.75%|
The 2 analysts offering 12-month price forecasts for IntelliPharmaCeutics International Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +96.56% increase from the last price of 4.07.
The current consensus among 2 polled investment analysts is to Buy stock in IntelliPharmaCeutics International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.